FIELD: chemistry.
SUBSTANCE: invention relates to an optically active form of (-)-O-exo/C-exo-tricyclo[5.2.1.02,6]-dec-9-yl xanthic acid, having antiviral activity. The invention also relates to a pharmaceutical composition containing said compound, a method of inhibiting activity of phospholipase C, a method of treating diseases caused by a virus, such as herpes simplex virus-1, herpes simplex virus-2 or papilloma virus, for example, for treating warts, cervical dysplasia, recurrent respiratory papillomatosis, or cancer associated with papillomavirus infection, and methods of producing said compound.
EFFECT: high efficiency of using said compounds.
29 cl, 7 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TENOFOVIR PRODRUG AND PHARMACEUTICAL USES THEREOF | 2013 |
|
RU2664534C9 |
| VITAMIN C AND CHROME-FREE VITAMIN K AND THEREOF-CONTAINING COMPOSITIONS FOR TREATMENT OF NFKB-MEDIATED CONDITION OR DISEASE | 2011 |
|
RU2575833C2 |
| PHARMACEUTICAL COMBINATION COMPRISING IBAT-INHIBITOR AND BILE ACID BINDER | 2011 |
|
RU2619215C2 |
| BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TREATING CANCER | 2015 |
|
RU2741914C2 |
| ANTI-RETROVIRAL COMBINATION | 2014 |
|
RU2675831C2 |
| ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE | 2011 |
|
RU2611437C2 |
| ANTIRETROVIRAL COMBINATION | 2008 |
|
RU2531089C2 |
| PHARMACEUTICAL COMPOSITION, CONTAINING ANTAGONIST OF P2X-RECEPTOR AND NONSTEROID ANTIINFLAMMATORY MEDICAL PRODUCT | 2004 |
|
RU2338556C2 |
| SOME CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2010 |
|
RU2582676C2 |
| PYRIMIDINE SUBSTITUTED MACROCYCLIC HCV INHIBITORS | 2008 |
|
RU2481340C2 |
